Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study

NCT02844270 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Diseases

Interventions

DEVICE: Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Sponsor

Shanghai Bio-heart Biological Technology Co., Ltd.